Pfizer announcement welcomed by industry - BPCI

BioPharmaChem Ireland (BPCI), the Ibec group that represents the biopharma and chemical sector in Ireland, has welcomed the announcement from Pfizer of plans to develop a new manufacturing facility worth €1.2bn. The investment will see the creation of between 400-500 new permanent jobs in the company and represents the single largest investment from Pfizer in Ireland to date. 

Welcoming the announcement, BPCI Director Matt Moran: “This is fantastic news for Pfizer and for the biopharma sector and broader economy as a whole. This critical industry exports more than €100 billion worth of goods annually and employs over 42,000 directly and responsible for the same number of employees again indirectly.
 
“To underpin the sector’s continued growth and capacity to compete internationally for resources and talent, it is imperative that the industry continues to invest in these kind of advanced manufacturing projects. It is great to see Pfizer endorse the Irish business model, and BPCI and the wider industry warmly welcome this investment.”